Institute of Pharmaceutical Science

Research output

Research output per year 1983 2000 2002 2003 2004 2005 2006 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2025

• 214896 Citations
• 3901 Article
• 185 Meeting abstract
• 171 Review article
• 152 Literature review
• 504 More
  • 127 Chapter
  • 105 Conference paper
  • 75 Letter
  • 64 Editorial
  • 30 Book
  • 30 Comment/debate
  • 12 Preprint
  • 11 Meeting Abstract
  • 10 Patent
  • 8 Other contribution
  • 7 Poster abstract
  • 6 Paper
  • 5 Book/Film/Article review
  • 4 Short survey
  • 2 Conference contribution
  • 2 Other chapter contribution
  • 2 Digital or Visual Products
  • 1 Commissioned report
  • 1 Entry in encyclopedia/dictionary
  • 1 Foreword/postscript
  • 1 Special issue

Research output per year

Research output per year

Search results

• 2016

  An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors

  Jamshidi, S., Sutton, M. & Rahman, K. M., 29 Jan 2016, (E-pub ahead of print) In: Future Medicinal Chemistry. 8, 2, p. 195-210 16 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Pump 100%
  • Organisms 40%
  • Antibiotics 20%
  22 Citations (Scopus)

• Design, fabrication and biomedical applications of zein-based nano/micro-carrier systems

  Zhang, Y., Cui, L., Li, F., Shi, N., Li, C., Yu, X., Chen, Y. & Kong, W., 20 Nov 2016, In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 513, 1–2, p. 191-210 20 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Protein 100%
  • Composite Material 50%
  • Microparticle 50%
  • Coating 50%
  • Biocompatibility 50%
  121 Citations (Scopus)

• Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota

  Dobbs, S. M., Dobbs, R. J., Weller, C., Charlett, A., Augustin, A. D., Taylor, D. M., Ibrahim, M. A. A. & Bjarnason, I. I., Feb 2016, In: Journal of NeuroVirology. 22, 1, p. 22-32

  Research output: Contribution to journal › Literature review › peer-review

  Open Access

  File

  • Parkinson's Disease 100%
  • Mediator 100%
  • Drug Therapy 50%
  • Antiparkinson Agent 33%
  • Immunoglobulin 33%
  41 Citations (Scopus)

  205 Downloads (Pure)
• 2015

  Pharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?

  Spina, D., 16 Mar 2015, In: Eur Clin Respir J. 2, 15 p., 26634.

  Research output: Contribution to journal › Literature review › peer-review

  • Therapeutic Procedure 100%
  • Disease 100%
  • Chronic Obstructive Pulmonary Disease 100%
  • Bronchodilating Agent 100%
  • Chronic Obstructive Lung Disease 100%

• Role of platelets in allergic airway inflammation

  Pitchford, S. C., Page, C. P. & Idzko, M., 2015, In: Journal of Allergy and Clinical Immunology.

  Research output: Contribution to journal › Literature review › peer-review
  63 Citations (Scopus)
• 2014

  Antipsychotics use in children and adolescents: An on-going challenge in clinical practice

  Schneider, C., Taylor, D., Zalsman, G., Frangou, S. & Kyriakopoulos, M., Jul 2014, In: Journal of Psychopharmacology. 28, 7, p. 615-623 9 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Drug Therapy 100%
  • Childhood 100%
  • Adolescence 100%
  • Child 100%
  • Therapeutic Procedure 66%
  32 Citations (Scopus)

• Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses

  Forbes, B., O'Lone, R., Allen, P. P., Cahn, A., Clarke, C., Collinge, M., Dailey, L. A., Donnelly, L. E., Dybowski, J., Hassall, D., Hildebrand, D., Jones, R., Kilgour, J., Klapwijk, J., Maier, C. C., McGovern, T., Nikula, K., Parry, J. D., Reed, M. D., Robinson, I., & 2 othersTomlinson, L. & Wolfreys, A., May 2014, In: ADVANCED DRUG DELIVERY REVIEWS. 71, p. 15-33 19 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Drug Development 100%
  • Drug Discovery 100%
  • Risk Assessment 100%
  • Human 50%
  • Inhalation 50%
  75 Citations (Scopus)

• Challenges in the diagnosis of ethylene glycol poisoning

  McQuade, D. J., Dargan, P. I. & Wood, D. M., Mar 2014, In: Annals of Clinical Biochemistry. 51, 2, p. 167-178 12 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Ethylene Glycol Poisoning 100%
  • Acidosis 33%
  50 Citations (Scopus)

• Current and novel bronchodilators in respiratory disease

  Spina, D., Jan 2014, In: Current Opinion in Pulmonary Medicine. 20, 1, p. 73-86 14 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Chronic Obstructive Lung Disease 100%
  • Aclidinium Bromide 50%
  • Tiotropium Bromide 50%
  • Olodaterol 50%
  • Umeclidinium 50%
  38 Citations (Scopus)

• Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases

  Abbott-Banner, K. H. & Page, C. P., May 2014, In: Basic and Clinical Pharmacology and Toxicology. 114, 5, p. 365-376 12 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  Open Access

  • Chronic Obstructive Lung Disease 100%
  • Anti-Inflammatory Drug 42%
  • Oxide 14%
  83 Citations (Scopus)

• Opioid Neonatal Abstinence Syndrome: controversies and implications for practice

  Wolff, K. & Perez-Montejano, R., Apr 2014, In: Current Drug Abuse Reviews. 7, 1, p. 44-58 15 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Neonatal Abstinence Syndrome 100%
  • Drug 20%
  • Methadone 20%
  • Neonates 20%
  • Symptom 20%
  19 Citations (Scopus)

• PDE inhibitors currently in early clinical trials for the treatment of asthma

  Matera, M. G., Page, C. & Cazzola, M., Sept 2014, In: Expert Opinion on Investigational Drugs. 23, 9, p. 1267-1275 9 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Clinical Trial 100%
  • Anti-Inflammatory Drug 12%
  44 Citations (Scopus)

• Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation

  Cazzola, M., Calzetta, L., Page, C. P. & Matera, M. G., Jan 2014, In: Expert Opinion On Drug Metabolism & Toxicology. 10, 1, p. 129-137 9 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Chronic Obstructive Lung Disease 100%
  • Indacaterol 100%
  • Elimination 14%
  • CYP3A 14%
  22 Citations (Scopus)
• 2013

  A review of the adverse effects and safety of noradrenergic antidepressants

  Whiskey, E. & Taylor, D., Aug 2013, In: Journal of Psychopharmacology. 27, 8, p. 732-739 8 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Toxic Injury 100%
  • Norepinephrine Reuptake Inhibitor 100%
  • Urinary Hesitancy 100%
  53 Citations (Scopus)

• ATR-FTIR spectroscopic imaging: recent advances and applications to biological systems

  Kazarian, S. G. & Chan, K. L. A., 7 Apr 2013, In: Analyst. 138, 7, p. 1940-1951 12 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Investigation 100%
  • Reflection 100%
  • Transform 100%
  • Imaging Method 100%
  • Application 100%
  327 Citations (Scopus)

• Challenges and opportunities for faecal microbiota transplantation therapy

  Rogers, G. B. & Bruce, K. D., Nov 2013, In: Epidemiology and Infection. 141, 11, p. 2235-2242 8 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Therapeutic Procedure 100%
  • Fecal Microbiota Transplantation 100%
  • Feces microflora 100%
  • Transplant Procedure 100%
  • Aptitude 66%
  9 Citations (Scopus)

• Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors: Implications for Therapeutic Drug Monitoring

  Josephs, D., Fisher, D., Spicer, J. & Flanagan, B., Oct 2013, In: Therapeutic Drug Monitoring. 35, 5, p. 562-587 26 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Clinical Pharmacokinetics 100%
  79 Citations (Scopus)

• Interpreting infective microbiota: the importance of an ecological perspective

  Rogers, G. B., Hoffman, L. R., Carroll, M. P. & Bruce, K. D., Jun 2013, In: Trends in Microbiology. 21, 6, p. 271-276 6 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Infection 100%
  • Microflora 100%
  • Species 50%
  • Aptitude 25%
  • Cystic Fibrosis 25%
  61 Citations (Scopus)

• Is there an association between microbial exposure and food allergy? A systematic review

  Marrs, T., Bruce, K. D., Logan, K., Rivett, D. W., Perkin, M. R., Lack, G. & Flohr, C., Jun 2013, In: Pediatric Allergy and Immunology. 24, 4, p. 311-320.e8 10 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Association 100%
  • Food Allergy 100%
  • Systematic Review 100%
  • Sensitization 30%
  • Cross Sectional Study 30%
  80 Citations (Scopus)

• Parkinson disease: from pathology to molecular disease mechanisms

  Dexter, D. T. & Jenner, P., Sept 2013, In: Free Radical Biology and Medicine. 62, N/A, p. 132-144 13 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Parkinson's Disease 100%
  • Dopaminergic 50%
  • Brain 50%
  • Neurodegenerative Disorder 25%
  • Neuroprotective Agent 25%
  560 Citations (Scopus)

• Parkinson's Disease - the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis

  Jenner, P., Morris, H. R., Robbins, T. W., Goedert, M., Hardy, J., Ben-Shlomo, Y., Bolam, P., Burn, D., Hindle, J. V., Brooks, D. & Parkinson's UK Discussion Grp, 27 Mar 2013, In: Journal of parkinsons disease. 3, 1, p. 1-11 11 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  Open Access

  • Parkinson's Disease 100%
  • Phenomenology 100%
  • Genetics 100%
  • Dementia with Lewy Bodies 12%
  60 Citations (Scopus)

• Pathogenesis of Parkinson's Disease

  Hirsch, E. C., Jenner, P. & Przedborski, S., Jan 2013, In: Movement Disorders. 28, 1, p. 24-30 7 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Parkinson's Disease 100%
  • Mitochondrion 20%
  • Behavior (Neuroscience) 20%
  • Neurodegenerative Disorder 20%
  • Neuroprotective Agent 20%
  233 Citations (Scopus)
• 2012

  Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials

  Lamaziere, A., Wolf, C. & Quinn, P. J., Apr 2012, In: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 13, 5, p. 736 - 745 10 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Lipogenesis 100%
  • Clinical Trial 100%
  • Drug Development 100%
  • Lipid 75%
  • Metabolite 25%
  3 Citations (Scopus)

• A systematic review of the evidence of clozapine's anti-aggressive effects

  Frogley, C., Taylor, D., Dickens, G. & Picchioni, M., Oct 2012, In: International Journal of Neuropsychopharmacology . 15, 9, p. 1351-1371 21 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Clozapine 100%
  • Antipsychotic 25%
  • Randomized Controlled Trial 25%
  • Pervasive Developmental Disorder 12%
  • Bipolar Disorder 12%
  175 Citations (Scopus)

• Chelating Agents for the Treatment of Systemic Iron Overload

  Ma, Y., Zhou, T., Kong, X. & Hider, R. C., Jun 2012, In: Current Medicinal Chemistry. 19, 17, p. 2816-2827 12 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Iron Poisoning 100%
  • Clinical Trial 20%
  • Deferiprone 20%
  • Deferasirox 20%
  • Deferitazole 20%
  74 Citations (Scopus)

• Emerging anti-inflammatory strategies for CORD

  Cazzola, M., Page, C. P., Calzetta, L. & Matera, M. G., 1 Sept 2012, In: European Respiratory Journal. 40, 3, p. 724-741 18 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Neutrophil Granulocyte 100%
  • Macrophage 100%
  • Inflammation Response 100%
  • Lung 100%
  • Inflammatory Cell 100%
  92 Citations (Scopus)

• Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

  Rogers, G. B., Carroll, M. P. & Bruce, K. D., Feb 2012, In: British Journal of Pharmacology. 165, 4, p. 845 - 857 13 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Antibiotics 100%
  • Antibiotic Therapy 16%
  34 Citations (Scopus)

• Iron mobilization from transferrin by therapeutic iron chelating agents

  Evans, R. W., Kong, X. & Hider, R. C., Mar 2012, In: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 1820, 3, p. 282 - 290 9 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Iron 100%
  • Macrophage 6%
  • Protein 6%
  • Membrane 6%
  • Urea 6%
  37 Citations (Scopus)

• Lipid-lipid interactions in bilayer membranes: Married couples and casual liaisons

  Quinn, P. J., Jul 2012, In: Progress in Lipid Research. 51, 3, p. 179-198 20 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Lipid 100%
  • Bilayer Membrane 100%
  • Membrane 100%
  • Membrane Lipid 66%
  • Phase Transition 33%
  58 Citations (Scopus)

• Microemulsion-based media as novel drug delivery systems

  Lawrence, M. J. & Rees, G. D., Dec 2012, In: ADVANCED DRUG DELIVERY REVIEWS. 64, Supplement, p. 175-193 19 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Drug Delivery System 100%
  • Drug Delivery Vehicle 33%
  • Cosurfactant 16%
  354 Citations (Scopus)

• Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's disease

  Gershanik, O. & Jenner, P., Dec 2012, In: European Journal of Neurology. 19, 12, p. 1502-1508 7 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Therapeutic Procedure 100%
  • Drug 100%
  • Stimulation 100%
  • Drug Delivery 100%
  • Parkinson's Disease 100%
  38 Citations (Scopus)

• Pharmacology and Therapeutics of Bronchodilators

  Cazzola, M., Page, C. P., Calzetta, L. & Matera, M. G., Jul 2012, In: Pharmacological Reviews. 64, 3, p. 450-504 55 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Chronic Obstructive Lung Disease 100%
  • Umeclidinium 66%
  • Corticosteroid 33%
  • Aclidinium Bromide 33%
  • Olodaterol 33%
  384 Citations (Scopus)

• The functions of TRPA1 and TRPV1: moving away from sensory nerves

  Fernandes, B., Fernandes, M. & Keeble, J., May 2012, In: British Journal of Pharmacology. 166, 2, p. 510-521 12 p.

  Research output: Contribution to journal › Literature review › peer-review

  • TRPV1 100%
  • Non-Selective Cation Channel 50%
  • Receptor 14%
  • Endothelium 14%
  • Non-Neuronal Cell 14%
  326 Citations (Scopus)

• Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP)

  Wood, D. M. & Dargan, P. I., Sept 2012, In: CLINICAL TOXICOLOGY. 50, 8, p. 727-732 6 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Acute Toxicity 100%
  • Stimulant 33%
  • Biological Activity 33%
  29 Citations (Scopus)
• 2011

  Challenges in inhaled product development and opportunities for open innovation

  Forbes, B., Asgharian, B., Dailey, L. A., Ferguson, D., Gerde, P., Gumbleton, M., Gustavsson, L., Hardy, C., Hassall, D., Jones, R., Lock, R., Maas, J., McGovern, T., Pitcairn, G. R., Somers, G. & Wolff, R. K., Jan 2011, In: ADVANCED DRUG DELIVERY REVIEWS. 63, 1-2, p. 69 - 87 19 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Pharmacodynamics 100%
  • Dosimetry 100%
  • Drug Administration 49%
  • Inhalation 49%
  • Drug Solubility 49%
  103 Citations (Scopus)

• Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression

  Jenner, P., McCreary, A. C. & Scheller, D. K. A., Dec 2011, In: Journal of Neural Transmission. 118, 12, p. 1691-1702 12 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • Drug Delivery 100%
  • Clinical Trial 12%
  • Replacement Therapy 12%
  • Drug Dose 12%
  46 Citations (Scopus)

• Current strategies in the discovery of small-molecule biomarkers for Alzheimer's disease

  Whiley, L. & Legido-Quigley, C., 2011, In: Bioanalysis. 3, 10, p. 1121 - 1142 22 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Biological Marker 100%
  • Molecules 100%
  • Small Molecule 100%
  • Protein 100%
  • Nuclear Magnetic Resonance 100%
  14 Citations (Scopus)

• Design of clinically useful macromolecular iron chelators

  Zhou, T., Winkelmann, G., Dai, Z-Y. & Hider, R. C., Jul 2011, In: Journal of Pharmacy and Pharmacology. 63, 7, p. 893 - 903 11 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Iron Poisoning 100%
  • Chelation Therapy 100%
  46 Citations (Scopus)

• Do ethnobotanical and laboratory data predict clinical safety and efficacy of anti-malarial plants?

  Willcox, M., Benoit-Vical, F., Fowler, D., Bourdy, G., Burford, G., Giani, S., Graziose, R., Houghton, P., Randrianarivelojosia, M. & Rasoanaivo, P., 2011, In: Malaria Journal. 10, SUPPL. 1, S7.

  Research output: Contribution to journal › Literature review › peer-review

  • Antimalarial Agent 100%
  • Clinical Trial 33%
  • Clinical Study 16%
  38 Citations (Scopus)

• Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation

  Iravani, M. M. & Jenner, P., Dec 2011, In: Journal of Neural Transmission. 118, 12, p. 1661-1690 30 p., N/A.

  Research output: Contribution to journal › Literature review › peer-review

  • L-DOPA 100%
  • Parkinson's Disease 25%
  • Dopamine 16%
  • Replacement Therapy 11%
  • Drug Dose 11%
  71 Citations (Scopus)

• Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of L-threonine

  Dong, X., Quinn, P. J. & Wang, X., Jan 2011, In: BIOTECHNOLOGY ADVANCES. 29, 1, p. 11 - 23 13 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Acid 100%
  • Escherichia 50%
  • Coil 50%
  • Genetics 14%
  • Anabolism 14%
  121 Citations (Scopus)

• Methaemoglobinaemia associated with the use of cocaine and volatile nitrites as recreational drugs: a review

  Hunter, L., Gordge, L., Dargan, P. I. & Wood, D., Jul 2011, In: British Journal of Clinical Pharmacology. 72, 1, p. 18 - 26 9 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Recreational Drug 100%
  • Local Anesthetic Agent 10%
  • Phenacetin 10%
  • Methylthioninium Chloride 10%
  59 Citations (Scopus)

• Novel bronchodilators for the treatment of chronic obstructive pulmonary disease

  Matera, M. G., Page, C. P. & Cazzola, M., Aug 2011, In: Trends in Pharmacological Sciences. 32, 8, p. 495 - 504 10 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Chronic Obstructive Lung Disease 100%
  • Clinical Trial 20%
  • Corticosteroid 20%
  • Preclinical Study 20%
  92 Citations (Scopus)

• Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis

  Rogers, G., Hoffman, L. R. & Doering, G., Dec 2011, In: Journal Of Cystic Fibrosis. 10, 6, p. 387 - 400 14 p.

  Research output: Contribution to journal › Literature review › peer-review

  Open Access

  • Therapeutic Procedure 100%
  • Antimicrobial Therapy 100%
  • Patient with Cystic Fibrosis 100%
  • Lung Infection 100%
  • Lung 100%
  22 Citations (Scopus)

• Paradoxical pharmacology: turning our pharmacological models upside down

  Page, C., Apr 2011, In: Trends in Pharmacological Sciences. 32, 4, p. 197 - 200 4 p.

  Research output: Contribution to journal › Literature review › peer-review
  11 Citations (Scopus)

• PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease

  Diamant, Z. & Spina, D., Aug 2011, In: PULMONARY PHARMACOLOGY AND THERAPEUTICS. 24, 4, p. 353 - 360 8 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Targeted Therapy 100%
  • Chronic Obstructive Pulmonary Disease 100%
  • Phosphodiesterase IV Inhibitor 100%
  • Obstructive Airway Disease 100%
  • Roflumilast 100%
  52 Citations (Scopus)

• The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone)

  Dargan, P. I., Sedefov, R., Gallegos, A. & Wood, D., Jul 2011, In: Drug Testing And Analysis. 3, 7-8, p. 454 - 463 10 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Toxicology 100%
  • Cathinone 100%
  • Acute Toxicity 25%
  • Recreational Drug 25%
  122 Citations (Scopus)

• The potential application of iron chelators for the treatment of neurodegenerative diseases

  Hider, R. C., Roy, S., Ma, Y. M., Le Kong, X. & Preston, J., Mar 2011, In: Metallomics. 3, 3, p. 239 - 249 11 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Neurodegenerative Disorder 100%
  • Chelating Agent 100%
  • Iron 100%
  • Parkinson's Disease 33%
  • Brain 33%
  75 Citations (Scopus)

• Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset

  Rogers, G. B., Hoffman, L. R., Johnson, M. W., Mayer-Hamblett, N., Schwarze, J., Carroll, M. P. & Bruce, K. D., Mar 2011, In: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 11, 2, p. 197 - 206 10 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Biological Marker 100%
  • Indicator 100%
  • Assay 75%
  • Patient 50%
  • Disease 25%
  15 Citations (Scopus)
• 2010

  A lipid matrix model of membrane raft structure

  Quinn, P. J., Oct 2010, In: Progress in Lipid Research. 49, 4, p. 390 - 406 17 p.

  Research output: Contribution to journal › Literature review › peer-review

  • Lipid 100%
  • Membrane 100%
  • Protein 85%
  • Liquid 44%
  • Quasicrystallinity 33%
  83 Citations (Scopus)